"Among patients enrolled in the 8th cohort of the ongoing Kevetrin trial, results showed SIGNIFICANT ENHANCEMENT OF P21 EXPRESSION IN 50% OF THESE PATIENTS!!!. These findings represents a positive signal for the potential efficacy of Kevetrin in the treatment of cancer."